Revealing the Mechanism of Huazhi Rougan Granule in the Treatment of Nonalcoholic Fatty Liver Through Intestinal Flora Based on 16S rRNA, Metagenomic Sequencing and Network Pharmacology.

导出 LinkOut

翻译打印收藏纠错

作者： Yingying,Liu ^[1] ; Yingying,Tan ^[1] ; Jiaqi,Huang ^[1] ; Chao,Wu ^[1] ; Xiaotian,Fan ^[1] ; Antony,Stalin ^[2] ; Shan,Lu ^[1] ; Haojia,Wang ^[1] ; Jingyuan,Zhang ^[1] ; Fanqin,Zhang ^[1] ; Zhishan,Wu ^[1] ; Bing,Li ^[3] ; Zhihong,Huang ^[1] ; Meilin,Chen ^[1] ; Guoliang,Cheng ^[3] ; Yanfang,Mou ^[3] ; Jiarui,Wu ^[1]

作者单位： Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China. ^[1] Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, China. ^[2] State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Linyi, China. ^[3]

关键词 16s sequencing high-fat diet intestinal flora disorder network pharmacology nonalcoholic simple fatty liver

DOI 10.3389/fphar.2022.875700

PMID 35559233

发布时间 2023-08-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2022年13卷

875700页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Revealing the Mechanism of Huazhi Rougan Granule in the Treatment of Nonalcoholic Fatty Liver Through Intestinal Flora Based on 16S rRNA, Metagenomic Sequencing and Network Pharmacology.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Revealing the Mechanism of Huazhi Rougan Granule in the Treatment of Nonalcoholic Fatty Liver Through Intestinal Flora Based on 16S rRNA, Metagenomic Sequencing and Network Pharmacology.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除